{"schema_version":"secwatch.filing_event.v1","accession":"0001789769-22-000077","form_type":"8-K","ticker":"TIL","cik":"0001789769","company_name":"Instil Bio, Inc.","filed_at":"2022-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.045587+00:00","generated_at":"2026-06-23T15:36:37.151139+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Instil Bio appoints Tim Moore as COO, CTO Vijay Chiruvolu resigns","bullets":["Tim Moore appointed COO effective Sept 6, 2022; previously President/COO at PACT Pharma and EVP at Kite.","Moore receives $565K base salary, $100K signing bonus, 50% target bonus, and 750,000 stock option grant.","Separately, CTO Vijay Chiruvolu resigned on Sept 2, 2022; terms not disclosed.","Moore brings cell therapy manufacturing experience, including launch of Yescarta at Kite."],"urls":{"canonical":"https://secwatch.observer/filing/0001789769-22-000077","json":"https://secwatch.observer/filing/0001789769-22-000077.json","markdown":"https://secwatch.observer/filing/0001789769-22-000077.md","text":"https://secwatch.observer/filing/0001789769-22-000077.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1789769/000178976922000077/0001789769-22-000077-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1789769/000178976922000077/til-20220902.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T15:36:37.151139+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"91d38cb02d","claim":"Timothy L. Moore was appointed as Chief Operating Officer at Instil Bio, Inc..","evidence_excerpt":"On September 6, 2022 (the “Effective Date”), the board of directors (the “Board”) of Instil Bio, Inc. (the “Company”) appointed Timothy L. Moore as Chief Operating Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1789769/000178976922000077/0001789769-22-000077-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}